Just another Network site

Jazz Pharmaceuticals to Buy Celator for $1.5 Billion

  • Jazz Pharmaceuticals to Buy Gentium for $1 Billion DEC. 20, 2013
  • Jazz reincorporated in Ireland in 2012, after a tax inversion deal with Azur Pharma.
  • DealBook | Jazz Pharmaceuticals to Buy Celator for $1.5 Billion
  • LONDON – Jazz Pharmaceuticals said on Tuesday that it had agreed to buy Celator Pharmaceuticals, which makes a treatment for a form of leukemia, for $1.5 billion in cash.
  • “Celator Pharmaceuticals is a strong strategic fit with Jazz Pharmaceuticals,” Bruce Cozadd, the Jazz chairman and chief executive, said in a news release .

Read the full article, click here.


@Armstrong_Clean: “”Jazz Pharmaceuticals to Buy Celator for $1.5 Billion” by CHAD BRAY via NYT #sandiego #ceo”


The deal would further bolster Jazz’s portfolio by acquiring the maker of Vyxeos, a treatment for a form of leukemia.


Jazz Pharmaceuticals to Buy Celator for $1.5 Billion